SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-22-118641
Filing Date
2022-11-14
Accepted
2022-11-14 16:36:52
Documents
69
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q rnaz-20220930x10q.htm   iXBRL 10-Q 1198206
2 EXHIBIT-31.1 rnaz-20220930xex31d1.htm EX-31.1 14685
3 EXHIBIT-31.2 rnaz-20220930xex31d2.htm EX-31.2 13820
4 EXHIBIT-32.1 rnaz-20220930xex32d1.htm EX-32.1 5606
5 EXHIBIT-32.2 rnaz-20220930xex32d2.htm EX-32.2 5618
  Complete submission text file 0001104659-22-118641.txt   5100628

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA rnaz-20220930.xsd EX-101.SCH 51803
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rnaz-20220930_cal.xml EX-101.CAL 33697
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rnaz-20220930_def.xml EX-101.DEF 125035
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE rnaz-20220930_lab.xml EX-101.LAB 399807
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rnaz-20220930_pre.xml EX-101.PRE 279202
63 EXTRACTED XBRL INSTANCE DOCUMENT rnaz-20220930x10q_htm.xml XML 687530
Mailing Address 6 LIBERTY SQUARE #2382 BOSTON MA 02109
Business Address 6 LIBERTY SQUARE #2382 BOSTON MA 02109 857-301-6857
Transcode Therapeutics, Inc. (Filer) CIK: 0001829635 (see all company filings)

IRS No.: 811065054 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40363 | Film No.: 221386623
SIC: 2834 Pharmaceutical Preparations